01 1Cadila Pharmaceuticals
01 1NATEGLINIDE FORM H USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-07
Pay. Date : 2013-07-19
DMF Number : 26518
Submission : 2013-06-21
Status : Active
Type : II
20
Cadila Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NATEGLINIDE FORM H USP, with a corresponding US DMF Number 26518.
Remarkably, this DMF maintains an Active status since its submission on June 21, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 07, 2014, and payment made on July 19, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
